logo-loader
Open Orphan Plc

Full interview: Open Orphan's Maurice Treacy talks genomics and its health databank

Open Orphan PLC's (LON:ORPH) chief commercial officer Maurice Treacy caught up with Proactive London's Andrew Scott for a chat on their health databank.

Also up for discussion is how Genomic Orphan Health data will work and how important GDPR is to ensure privacy and security.

Quick facts: Open Orphan Plc

Price: 6.7 GBX

Market: AIM
Market Cap: £17.06 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan Plc named herein, including the promotion by the Company of Open Orphan Plc in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Open Orphan 'driving research for novel drug development for rare diseases'

Proactive London sits down with Open Orphan PLC's (LON:ORPH) chief commercial officer Maurice Treacy. Treacy discusses how he became involved with Open Orphan and his ambitions for the firm's health data initiative. ''Many rare diseases aren't known or badly diagnosed ... but rare isn't...

on 16/9/19

2 min read